ProfileGDS4718 / 213286_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 83% 75% 63% 68% 83% 83% 69% 60% 61% 62% 77% 74% 82% 81% 60% 66% 84% 80% 90% 73% 67% 58% 62% 69% 82% 63% 82% 63% 76% 77% 79% 76% 58% 85% 86% 82% 74% 75% 78% 64% 73% 77% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1326960
GSM549102patient 115, normal, homogenized [OPG study]8.1657283
GSM549104patient 119, normal, homogenized [OPG study]7.3497775
GSM549108patient 138, normal, homogenized [OPG study]6.3644663
GSM549119patient 077, normal, homogenized [OPG study]6.7063668
GSM549133patient 032, cancer, homogenized [OPG study]8.317283
GSM549139patient 042, cancer, homogenized [OPG study]8.2290983
GSM549099patient 107, normal, homogenized [OPG study]6.7218469
GSM549109patient 139, normal, homogenized [OPG study]6.1646960
GSM549110patient 046, normal, homogenized [OPG study]6.1957161
GSM549114patient 063, normal, homogenized [OPG study]6.2627762
GSM549122patient 082, normal, homogenized [OPG study]7.4967677
GSM549134patient 033, cancer, homogenized [OPG study]7.2788774
GSM549136patient 036, cancer, homogenized [OPG study]8.2252382
GSM549140patient 044, cancer, homogenized [OPG study]8.0684581
GSM549111patient 047, normal, homogenized [OPG study]6.097160
GSM549113patient 057, normal, homogenized [OPG study]6.5283466
GSM549132patient 031, cancer, homogenized [OPG study]8.3583984
GSM549137patient 038, cancer, homogenized [OPG study]7.8577180
GSM549142patient 047, cancer, homogenized [OPG study]8.7339290
GSM549100patient 110, normal, homogenized [OPG study]7.0720273
GSM549107patient 135, normal, homogenized [OPG study]6.6165767
GSM549115patient 068, normal, homogenized [OPG study]5.9524458
GSM549116patient 072, normal, homogenized [OPG study]6.2964862
GSM549120patient 078, normal, homogenized [OPG study]6.7987669
GSM549131patient 030, cancer, homogenized [OPG study]8.1654282
GSM549118patient 074, normal, homogenized [OPG study]6.3236863
GSM549129patient 027, cancer, homogenized [OPG study]8.0663882
GSM549123patient 088, normal, homogenized [OPG study]6.3412963
GSM549124patient 006, cancer, homogenized [OPG study]7.3692476
GSM549126patient 015, cancer, homogenized [OPG study]7.4993877
GSM549128patient 025, cancer, homogenized [OPG study]7.8502279
GSM549103patient 117, normal, homogenized [OPG study]7.279576
GSM549117patient 073, normal, homogenized [OPG study]5.9359458
GSM549138patient 041, cancer, homogenized [OPG study]8.4457185
GSM549141patient 045, cancer, homogenized [OPG study]8.7301186
GSM549130patient 028, cancer, homogenized [OPG study]8.0373482
GSM549101patient 111, normal, homogenized [OPG study]7.2302474
GSM549105patient 128, normal, homogenized [OPG study]7.3168175
GSM549106patient 134, normal, homogenized [OPG study]7.7427578
GSM549112patient 048, normal, homogenized [OPG study]6.3967864
GSM549125patient 011, cancer, homogenized [OPG study]7.1391973
GSM549127patient 024, cancer, homogenized [OPG study]7.6062177
GSM549135patient 035, cancer, homogenized [OPG study]8.1340181